About
Alzheimer's Focused Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
124
By Phase
PHASE2: 1PHASE1: 3EARLY_PHASE1: 1
By Status
COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05416931Lead Sponsor
ACD440 Gel in Peripheral Neuropathic Pain
PHASE2Completed
14 participants
Started: Jun 20, 2022 · Completed: Mar 10, 2023
NCT05077501Lead Sponsor
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856
PHASE1Completed
24 participants
Started: Sep 29, 2021 · Completed: May 23, 2022
NCT05077631Lead Sponsor
Study to Evaluate the Effects of Single Ascending Oral Doses of ACD856 on Safety, Tolerability and Pharmacokinetics
PHASE1Completed
56 participants
Started: Feb 15, 2021 · Completed: Feb 22, 2022
NCT04704232Lead Sponsor
Study of Safety, Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers
PHASE1Completed
24 participants
Started: Jan 12, 2021 · Completed: Mar 10, 2021
NCT05783830Lead Sponsor
Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856
EARLY_PHASE1Completed
6 participants
Started: Jan 13, 2020 · Completed: Apr 18, 2020
Locations (1)
Headquarters
Huddinge, Sweden
Map
Loading map...